Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study

Norihiro Nishimoto,Koichi Amano,Yasuhiko Hirabayashi,Takahiko Horiuchi,Tomonori Ishii,Mitsuhiro Iwahashi,Masahiro Iwamoto,Hitoshi Kohsaka,Masakazu Kondo,Tsukasa Matsubara,Toshihide Mimura,Hisaaki Miyahara,Shuji Ohta,Yukihiko Saeki,Kazuyoshi Saito,Hajime Sano,Kiyoshi Takasugi,Tsutomu Takeuchi,Shigeto Tohma,Tomomi Tsuru,Yukitaka Ueki,Jiro Yamana,Jun Hashimoto,Takaji Matsutani,M. Murakami,Nobuhiro Takagi

Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study

2013

Objectives To evaluate the safety and efficacy of retreatment with tocilizumab (TCZ) in patients who had participated in the DREAM study (Drug free remission/low disease activity after cessation of tocilizumab [Actemar] monotherapy study) and had experienced loss of efficacy.

Keywords:

Tocilizumab
Rheumatology
Rheumatoid arthritis
Physical therapy
Disease
Interleukin 6
Internal medicine
Medicine
Severity of illness
Diabetes mellitus
Infliximab
Antirheumatic Agents

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations